This compound is a synthetic, stereochemically defined molecule featuring a central tetrahydropyran ring substituted with multiple acetate groups, a methylthio group, and a chlorinated biphenyl moiety bearing an ethoxyphenyl substituent. Its structure indicates potential use as a research chemical or synthetic intermediate in medicinal chemistry.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1018899-03-0
(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
pharmaceutical intermediate for dapagliflozin
AMMONIUM BISULFITE
n.a
1H,1H,2H,2H-Perfluorodecyltriethoxysilane
n.a
Hydrazinium hydrazinecarboxylate
n.a
N2-Tritylolmesartan medoxomil
n.a
(2S,3S,4R,5S,6R)-2-(3-(4-chlorobenzyl)-4-methylphenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triyl triacetate
Pharmaceutical intermediate
Sotagliflozin
active pharmaceutical ingredient
((2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-(4-chloro-3-((4-hydroxyphenyl)methyl)phenyl)oxan-2-yl)methyl acetate
pharmaceutical intermediate
[(2S,3S,4R,5S,6R)-3,5-diacetyloxy-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyloxan-4-yl] acetate
ABNIXBQXMYTWSJ-UIPNDDLNSA-N
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)SC)OC(=O)C)OC(=O)C)OC(=O)C)Cl